PL1904029T5 - Podawana doustnie, nie dająca się wypluć folia, ulegająca szybkiemu rozkładowi, zawierająca olanzapinę - Google Patents

Podawana doustnie, nie dająca się wypluć folia, ulegająca szybkiemu rozkładowi, zawierająca olanzapinę

Info

Publication number
PL1904029T5
PL1904029T5 PL06776333T PL06776333T PL1904029T5 PL 1904029 T5 PL1904029 T5 PL 1904029T5 PL 06776333 T PL06776333 T PL 06776333T PL 06776333 T PL06776333 T PL 06776333T PL 1904029 T5 PL1904029 T5 PL 1904029T5
Authority
PL
Poland
Prior art keywords
olanzapin
oral
spit out
disintegrating film
quickly disintegrating
Prior art date
Application number
PL06776333T
Other languages
English (en)
Other versions
PL1904029T3 (pl
Inventor
Petra Obermeier
Thomas Kohr
Kai-Thomas Kramer
Karin Klokkers
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37156035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1904029(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of PL1904029T3 publication Critical patent/PL1904029T3/pl
Publication of PL1904029T5 publication Critical patent/PL1904029T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL06776333T 2005-07-20 2006-07-20 Podawana doustnie, nie dająca się wypluć folia, ulegająca szybkiemu rozkładowi, zawierająca olanzapinę PL1904029T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005033943A DE102005033943A1 (de) 2005-07-20 2005-07-20 Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
EP06776333.4A EP1904029B2 (de) 2005-07-20 2006-07-20 Nicht-ausspuckbarer, oraler, schnell-zerfallender film enthaltend olanzapin
PCT/EP2006/007177 WO2007009801A2 (de) 2005-07-20 2006-07-20 Nicht-ausspuckbarer, oraler, schnell-zerfallender film für ein neuroleptikum

Publications (2)

Publication Number Publication Date
PL1904029T3 PL1904029T3 (pl) 2011-06-30
PL1904029T5 true PL1904029T5 (pl) 2015-05-29

Family

ID=37156035

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06776333T PL1904029T5 (pl) 2005-07-20 2006-07-20 Podawana doustnie, nie dająca się wypluć folia, ulegająca szybkiemu rozkładowi, zawierająca olanzapinę

Country Status (17)

Country Link
US (1) US20080200452A1 (pl)
EP (1) EP1904029B2 (pl)
JP (1) JP5551361B2 (pl)
CN (1) CN101287445A (pl)
AT (1) ATE496616T1 (pl)
AU (1) AU2006271865B2 (pl)
BR (1) BRPI0613683A2 (pl)
CA (1) CA2615533C (pl)
DE (2) DE102005033943A1 (pl)
ES (1) ES2358607T5 (pl)
MX (1) MX2008000847A (pl)
PL (1) PL1904029T5 (pl)
PT (1) PT1904029E (pl)
RU (1) RU2427374C2 (pl)
SI (1) SI1904029T2 (pl)
WO (1) WO2007009801A2 (pl)
ZA (1) ZA200800976B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2711932A1 (en) * 2008-01-31 2009-08-13 Mcneil-Ppc, Inc. Edible film-strips for immediate release of active ingredients
EP2674150A1 (de) * 2009-01-28 2013-12-18 Labtec GmbH Pharmazeutische Zubereitung mit verbesserter Stabilität des Wirkstoffs
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
JP5751868B2 (ja) * 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
EP2566467A1 (de) 2010-05-07 2013-03-13 Hexal Aktiengesellschaft Mucosaler film enthaltend zwei zuckeraustauschstoffe
DE102010049706A1 (de) 2010-10-28 2012-05-03 Hexal Ag Herstellung orodispersibler Filme
DE102010049708A1 (de) 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
WO2013084590A1 (ja) * 2011-12-09 2013-06-13 Dic株式会社 造膜助剤ならびにそれを含有する水性樹脂組成物及び鋼板表面処理剤
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
CN102920683B (zh) * 2012-06-11 2013-08-14 江苏豪森药业股份有限公司 奥氮平口腔速溶膜
US20160000714A1 (en) 2013-03-06 2016-01-07 Capsugel Belgium Nv Curcumin solid lipid particles and methods for their preparation and use
EP3766480A1 (en) * 2014-06-10 2021-01-20 Capsugel Belgium NV Orally disintegrating tablet containing solid lipid particles and methods for their preparation and use
MY189110A (en) * 2014-06-24 2022-01-26 Catherine LEE Fast acting orally disintegrating film
WO2016009001A1 (en) 2014-07-17 2016-01-21 Hexal Ag Orodispersible film
WO2016087261A1 (en) 2014-12-04 2016-06-09 Capsugel Belgium N.V. Lipid multiparticulate formulations
US20170216220A1 (en) * 2016-02-03 2017-08-03 Intelgenx Corp. Loxapine film oral dosage form
US11648212B2 (en) * 2016-02-03 2023-05-16 Intelgenx Corp. Loxapine film oral dosage form
DE102017103346A1 (de) 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
CN107823191B (zh) * 2017-11-16 2021-04-09 广州迈达康医药科技有限公司 一种帕利哌酮口服速溶膜制剂及其制备工艺
GR20200100430A (el) * 2020-06-01 2022-01-13 Κυριακος Ηλια Κυπραιος Ταχεως διαλυομενες στοματικες ταινιες για τη χορηγηση δια της στοματικης οδου φαρμακων και λοιπων βιοδραστικων ουσιων σε ανθρωπους
KR102501784B1 (ko) * 2020-11-02 2023-02-20 아주대학교산학협력단 난용성 약물을 포함하는 구강 붕해 필름 제조방법
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2022103636A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Improved use of cannabinoids in the treatment of alzheimer's disease

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317214A (en) * 1980-07-14 1982-02-23 Attinello John S Apparatus for simulating interference transmissions
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions
USRE33093E (en) * 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4820506A (en) * 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
JPH03232817A (ja) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk 貼付剤
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
US5766620A (en) * 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
US5955097A (en) * 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US20050048102A1 (en) * 1997-10-16 2005-03-03 Virotex Corporation Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
AU2978400A (en) * 1999-02-02 2000-08-25 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices
BR0009437A (pt) * 1999-03-31 2002-01-15 Janssen Pharmaceutica Nv Amido pré-gelatinizado em uma formulação de liberação controlada
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030124176A1 (en) * 1999-12-16 2003-07-03 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US6828308B2 (en) * 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation
JP2002338456A (ja) * 2001-05-14 2002-11-27 ▲高▼田 ▲寛▼治 小腸粘膜付着性貼付剤Ｇａｓｔｒｏｉｎｔｅｓｔｉｎａｌｍｕｃｏａｄｈｅｓｉｖｅｐａｔｃｈｓｙｓｔｅｍ（ＧＩ−ＭＡＰＳ）の製造法
JP2003125679A (ja) * 2001-10-19 2003-05-07 Shimano Inc ベイトリール
US20040247649A1 (en) * 2002-02-11 2004-12-09 Edizone, Lc Medicine-containing orally soluble films
JP2004043450A (ja) * 2002-05-16 2004-02-12 Kyukyu Yakuhin Kogyo Kk 速溶性フィルム状製剤
EP1413887A1 (en) * 2002-10-22 2004-04-28 Aventis Pharma S.A. Inhibitors of Src kinase for use in Alzheimer's disease
US20040151774A1 (en) * 2002-10-31 2004-08-05 Pauletti Giovanni M. Therapeutic compositions for drug delivery to and through covering epithelia
JP4443903B2 (ja) * 2002-12-02 2010-03-31 救急薬品工業株式会社 積層フィルム状可食性口腔内投与剤の製造方法
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
RU2005129309A (ru) * 2003-05-02 2006-05-10 Уорнер-Ламберт Компани Эл-Эл-Си (US) Пригодные для перорального употребления быстрорастворимые пленки, содержащие модифицированный крахмал для улучшенной тепло-и влагоустойчивости
TW200514579A (en) * 2003-07-24 2005-05-01 Smithkline Beecham Corp Orally dissolving films
WO2005016321A1 (en) * 2003-08-15 2005-02-24 Qlt Usa, Inc. Adhesive bioerodible transmucosal drug delivery system
US7470397B2 (en) † 2003-10-24 2008-12-30 Adhesives Research, Inc. Disintegratable films for diagnostic devices

Also Published As

Publication number Publication date
WO2007009801A2 (de) 2007-01-25
RU2008105830A (ru) 2009-11-10
SI1904029T2 (sl) 2015-01-30
RU2427374C2 (ru) 2011-08-27
MX2008000847A (es) 2008-03-26
EP1904029A2 (de) 2008-04-02
CA2615533A1 (en) 2007-01-25
AU2006271865B2 (en) 2011-08-25
ES2358607T5 (es) 2014-12-05
DE102005033943A1 (de) 2007-02-22
DE502006008816D1 (de) 2011-03-10
ATE496616T1 (de) 2011-02-15
ZA200800976B (en) 2009-08-26
CN101287445A (zh) 2008-10-15
SI1904029T1 (sl) 2011-04-29
JP5551361B2 (ja) 2014-07-16
JP2009501752A (ja) 2009-01-22
EP1904029B1 (de) 2011-01-26
WO2007009801A3 (de) 2007-06-21
PT1904029E (pt) 2011-03-16
BRPI0613683A2 (pt) 2011-01-25
US20080200452A1 (en) 2008-08-21
EP1904029B2 (de) 2014-11-12
ES2358607T3 (es) 2011-05-12
PL1904029T3 (pl) 2011-06-30
AU2006271865A1 (en) 2007-01-25
HK1112843A1 (en) 2008-09-19
CA2615533C (en) 2014-04-08

Similar Documents

Publication Publication Date Title
PL1904029T3 (pl) Podawana doustnie, nie dająca się wypluć folia, ulegająca szybkiemu rozkładowi, zawierająca olanzapinę
WO2007009800A3 (de) Nicht-ausspuckbarer, oraler, schnell-zerfallender film für antiemetikum oder antimigränemittel
WO2006081251A3 (en) Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
WO2007045252A3 (en) An edible composition
WO2005041924A3 (en) Administration of levodopa and carbidopa
EP2450360A3 (en) (S)-N-Methylnaltrexone
WO2007064885A3 (en) Oral care compositions, methods, devices and systems
TW200637522A (en) Skin treatment articles and methods
NO20075009L (no) Ernaeringstilsetning for HIV-pasienter
EP1919302B8 (en) Food comprising silicon
IL190079A0 (en) Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear
EP2241196A3 (en) Nutritional supplement comprising oligosaccharides and cysteine for treating hiv
MX2007012623A (es) Inulina de cadena larga.
MXPA05008902A (es) Soluciones de drogas en mentol.
GB2443793B (en) Product, method of manufacture and use
BRPI0506779A (pt) formulação de sorvete, e, sorvete
MX2007011264A (es) Composiciones nutricionales para modular la biodisponibilidad de vitamina c.
SG165324A1 (en) Compositions and methods to counteract oral malodour
GB0327390D0 (en) Pharmaceutical formulations
NO20051473L (no) Behandling mot brekninger.
ITMI20001090A0 (it) Procedimento per la preparazione di agglomerati stabilizzati da cenere i lolla e paglia di riso.
UA66456C2 (uk) Лікарський засіб кардіологічної дії
WO2006020984A3 (en) Cyclosporin formulations
GEP20084559B (en) Medicinal-prevention means
MX2008015058A (es) Formulaciones de sal de prednisolona.